Emerging therapies such as pupil-modulating eye drops, multifocal lenses, and corneal inlays are reshaping the presbyopia treatment landscape. North America leads the market, while Asia-Pacific is witnessing rapid adoption due to expanding elderly care. https://www.datamintelligence.com/research-report/retinoblastoma-market